• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVOCURE GMBH OPTUNE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVOCURE GMBH OPTUNE Back to Search Results
Model Number TFH9100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Skin Erosion (2075); Post Traumatic Wound Infection (2447)
Event Date 08/01/2021
Event Type  Injury  
Manufacturer Narrative
Novocure's medical opinion is that a contribution of the arrays to wound infection and skin erosion cannot be ruled out.Contributing factors for skin erosion and wound infection in this patient include: prior radiation, underlying cancer disease and prior surgery affecting skin integrity.Wound infection is an expected event with device use and was reported as an adverse event in the ef-14 trial of optune together with temozolomide (tmz) compared to tmz alone in patients with newly diagnosed gbm in both arms of the trial (<1% and <1% in optune/tmz and tmz arms respectively).Skin erosion was reported as an adverse event in the ef-14 trial of optune together with temozolomide (tmz) compared to tmz alone in patients with newly diagnosed gbm in the tmz arm of the trial (<1%) only.
 
Event Description
A (b)(6) female patient with newly diagnosed glioblastoma (gbm) began optune therapy on (b)(6) 2021.On august 04, 2021, the patient reported that on (b)(6) 2021, she experienced redness, swelling and fever at the craniotomy surgical resection site.The patient was examined at the hospital, administered antibiotic drip infusion for a suspected wound infection on the scalp and discharged home.On (b)(6) 2021, the prescribing physician admitted the patient to the hospital for administration of unspecified antibiotics.Optune therapy was temporarily discontinued.The prescriber assessed the cause of the event as progressive skin erosion resulting in a wound infection after applying the transducer arrays.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTUNE
Type of Device
OPTUNE
Manufacturer (Section D)
NOVOCURE GMBH
business village d4
park 6/platz 10
root d4, 6039
SZ  6039
Manufacturer (Section G)
NOVOCURE GMBH
business village d4
park 6/platz 10
root d4, 6039
SZ   6039
Manufacturer Contact
sharon perez
195 commerce way
portsmouth, NH 03801
2077527602
MDR Report Key12525815
MDR Text Key273107337
Report Number3009453079-2021-00183
Device Sequence Number1
Product Code NZK
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 09/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberTFH9100
Device Catalogue NumberN/A
Device Lot NumberN/A
Initial Date Manufacturer Received 09/01/2021
Initial Date FDA Received09/24/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/17/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
NOT AVAILABLE
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age54 YR
-
-